scholarly journals Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial

2021 ◽  
Author(s):  
Joan T Price ◽  
Bellington Vwalika ◽  
Bethany L Freeman ◽  
Stephen R Cole ◽  
Pooja T Saha ◽  
...  
Keyword(s):  
Preterm Birth ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Women Living With Hiv ◽  
Hydroxyprogesterone Caproate ◽  
Living With Hiv

Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial

2007 ◽  
Vol 30 (5) ◽  
pp. 687-696 ◽  
Author(s):  
J. M. O'Brien ◽  
C. D. Adair ◽  
D. F. Lewis ◽  
D. R. Hall ◽  
E. A. DEfranco ◽  
...  
Keyword(s):  
Preterm Birth ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Vaginal Gel

scholarly journals 10 A randomized trial of 17-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV

2021 ◽  
Vol 224 (2) ◽  
pp. S6-S7
Author(s):  
Joan T. Price ◽  
Bellington Vwalika ◽  
Bethany L. Freeman ◽  
Pooja T. Saha ◽  
Stephen R. Cole ◽  
...  
Keyword(s):  
Preterm Birth ◽  
Randomized Trial ◽  
Women Living With Hiv ◽  
Hydroxyprogesterone Caproate ◽  
17 Hydroxyprogesterone ◽  
Living With Hiv

17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial

2015 ◽  
Vol 213 (3) ◽  
pp. 364.e1-364.e12 ◽  
Author(s):  
C. Andrew Combs ◽  
Thomas J. Garite ◽  
Kimberly Maurel ◽  
Diana Abril ◽  
Anita Das ◽  
...  
Keyword(s):  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Hydroxyprogesterone Caproate ◽  
17 Hydroxyprogesterone
Sign in / Sign up

Export Citation Format

Share Document